Get the Stockscreener App
0.5023
0.42%
0.0021
Oncolytics Biotech Inc Stock (ONCY) Forecast
The Oncolytics Biotech Inc (ONCY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.3691, representing a -26.52% decrease from the current price of $0.5023. The highest analyst price target is $0.6962, and the lowest is $0.0419.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ONCY Price Target
Average 0.3494
(-30.43% Downside)
Is Oncolytics Biotech Inc (ONCY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.19 | Neutral |
| STOCH(9,6) | 38.24 | Neutral |
| STOCHRSI(14) | 87.27 | Sell |
| MACD(12,26) | -0.0611 | Buy |
| ADX(14) | 33.58 | Sell |
| William %R | -63.88 | Neutral |
| CCI(14) | -26.18 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5056
Sell
|
0.5195
Sell
|
| MA20 |
0.5613
Sell
|
0.5635
Sell
|
| MA50 |
0.7053
Sell
|
0.6634
Sell
|
| MA100 |
0.7807
Sell
|
0.7497
Sell
|
| MA200 |
0.8772
Sell
|
0.8443
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ONCY could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ONCY, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.19 indicates that ONCY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.24 indicates that ONCY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 87.27 indicates that ONCY is oversold. This suggests that ONCY price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.58 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -26.18 indicates that ONCY is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ONCY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oncolytics Biotech Inc financial reports and earnings history, Oncolytics Biotech Inc (ONCY) stock could reach $0.1463 by 2030, $0.4562 by 2040 and $5.8706 by 2050. See the projected annual prices until 2050 of the Oncolytics Biotech Inc stock below:
- Oncolytics Biotech Inc (ONCY) is expected to reach an average price of $0.9567 in 2035, with a high prediction of $0.8517 and a low estimate of $0.8303. This indicates an $90.46% rise from the last recorded price of $0.5023.
- Oncolytics Biotech Inc (ONCY) stock is projected to chart a bullish course in 2040, with an average price target of $0.5708, representing an $13.64% surge from its current level. The forecast ranges from a conservative $0.6026 to a sky-high $0.4562.
- Our analysts predict Oncolytics Biotech Inc (ONCY) to jump 523.55% by 2045, soaring from $3.2835 to an average price of $3.1321, potentially reaching $3.535. While $3.2835 is the low estimate, the potential upside is significant.
- Oncolytics Biotech Inc (ONCY) stock is expected to climb by 2050, reaching an average of $5.9006, a $1,075% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8706 and $5.7595, respectively, highlighting the market's uncertainty.
Oncolytics Biotech Inc Stock (ONCY) Year by Year Forecast
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2026
The predicted value for Oncolytics Biotech Inc (ONCY) in 2026 is set at an average of $0.6579. Estimates vary from a peak of $1.30 to a trough of $0.0159, indicating an +30.98% surge from the present price of $0.5023.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.1719 | $0.0419 | $0.6962 | -65.77% |
| December, 2026 | $0.0123 | $0.0159 | $0.2898 | -97.54% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oncolytics Biotech Inc (ONCY) is $0.3059, with a high forecast of $0.6091 and a low forecast of $0.00267. This indicates an -39.10% decrease from the last price of $0.5023.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4234 | $0.0834 | $0.5534 | -15.71% |
| February, 2027 | $0.4391 | $0.1373 | $0.6091 | -12.58% |
| March, 2027 | $0.0887 | $0.0237 | $0.533 | -82.33% |
| April, 2027 | $0.1345 | $0.00267 | $0.2227 | -73.23% |
| May, 2027 | $0.0559 | $0.00769 | $0.2484 | -88.87% |
| June, 2027 | $0.2302 | $0.2702 | $0.2541 | -54.17% |
| July, 2027 | $0.3745 | $0.3064 | $0.3584 | -25.45% |
| August, 2027 | $0.3148 | $0.4038 | $0.3666 | -37.32% |
| September, 2027 | $0.1761 | $0.123 | $0.1109 | -64.94% |
| October, 2027 | $0.0767 | $0.0273 | $0.1748 | -84.73% |
| November, 2027 | $0.0937 | $0.0695 | $0.1305 | -81.34% |
| December, 2027 | $0.038 | $0.062 | $0.032 | -92.43% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2028
In 2028, Oncolytics Biotech Inc (ONCY) is projected to reach an average price of $1.1216, with a high projection of $2.2415 and a low estimate of $0.00159. This indicates an +123.29% rise from the last price of $0.5023.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5716 | $0.0041 | $1.0016 | +13.80% |
| February, 2028 | $0.3673 | $0.1573 | $0.7334 | -26.87% |
| March, 2028 | $0.5731 | $0.2809 | $0.7491 | +14.09% |
| April, 2028 | $0.4388 | $0.3248 | $0.6309 | -12.65% |
| May, 2028 | $0.1384 | $0.00159 | $0.5127 | -72.44% |
| June, 2028 | $0.0459 | $0.0177 | $0.1623 | -90.87% |
| July, 2028 | $0.5638 | $0.0719 | $0.5959 | +12.24% |
| August, 2028 | $0.3595 | $0.3595 | $1.0277 | -28.43% |
| September, 2028 | $1.9152 | $0.4234 | $2.2415 | +281.29% |
| October, 2028 | $1.1449 | $1.0749 | $2.2291 | +127.92% |
| November, 2028 | $1.1806 | $0.7928 | $1.3766 | +135.03% |
| December, 2028 | $1.0663 | $0.9163 | $1.3184 | +112.28% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2029
The 2029 price forecast for Oncolytics Biotech Inc Stock (ONCY) is $0.608 on average, with a high prediction of $1.2102 and a low estimate of $0.00584. This represents an +21.05% increase from the previous price of $0.5023.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4659 | $0.4109 | $1.2102 | -7.24% |
| February, 2029 | $0.4416 | $0.2477 | $0.7338 | -12.07% |
| March, 2029 | $0.3574 | $0.3174 | $0.6995 | -28.85% |
| April, 2029 | $0.197 | $0.1442 | $0.3713 | -60.78% |
| May, 2029 | $0.1427 | $0.1359 | $0.2952 | -71.59% |
| June, 2029 | $0.1484 | $0.0105 | $0.1845 | -70.45% |
| July, 2029 | $0.0881 | $0.00584 | $0.1924 | -82.46% |
| August, 2029 | $0.1338 | $0.0499 | $0.322 | -73.36% |
| September, 2029 | $0.1695 | $0.1277 | $0.3357 | -66.25% |
| October, 2029 | $0.0892 | $0.0592 | $0.2074 | -82.25% |
| November, 2029 | $0.1249 | $0.0731 | $0.1949 | -75.14% |
| December, 2029 | $0.0724 | $0.0355 | $0.1788 | -85.58% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2030
Oncolytics Biotech Inc Stock (ONCY) is expected to reach an average price of $0.3404 in 2030, with a high forecast of $0.6799 and a low forecast of $0.00082. This signifies an -32.24% decrease from the last price of $0.5023.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0862 | $0.0235 | $0.1463 | -82.83% |
| February, 2030 | $0.246 | $0.012 | $0.286 | -51.03% |
| March, 2030 | $0.3117 | $0.2738 | $0.6799 | -37.95% |
| April, 2030 | $0.1115 | $0.0913 | $0.3556 | -77.80% |
| May, 2030 | $0.1908 | $0.00082 | $0.257 | -62.01% |
| June, 2030 | $0.00375 | $0.0459 | $0.191 | -99.25% |
| July, 2030 | $0.042 | $0.0128 | $0.1168 | -91.64% |
| August, 2030 | $0.1218 | $0.1099 | $0.102 | -75.75% |
| September, 2030 | $0.1712 | $0.158 | $0.1901 | -65.91% |
| October, 2030 | $0.1973 | $0.1696 | $0.1465 | -60.72% |
| November, 2030 | $0.3408 | $0.2626 | $0.3308 | -32.15% |
| December, 2030 | $0.2387 | $0.0288 | $0.2836 | -52.47% |
3.09%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):